LOGO.png
Draganfly to be Featured on Bloomberg on The RedChip Money Report® January 15th
January 14, 2022 16:15 ET | Draganfly Inc
Los Angeles, CA., Jan. 14, 2022 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading drone solutions and...
Radisson Announces High-Grade Gold Intercepts on Globex’s Kewagama Royalty Property
January 13, 2022 08:00 ET | Globex Mining Enterprises Inc.
ROUYN-NORANDA, Quebec, Jan. 13, 2022 (GLOBE NEWSWIRE) -- GLOBEX MINING ENTERPRISES INC. (GMX – Toronto Stock Exchange, G1MN – Frankfurt, Stuttgart, Berlin, Munich, Tradegate, Lang & Schwarz, LS...
Radisson annonce des intersections aurifères de hautes teneurs sur la propriété à royauté Kewagama de Globex
January 13, 2022 08:00 ET | Entreprises Minières Globex Inc.
ROUYN-NORANDA, Québec, 13 janv. 2022 (GLOBE NEWSWIRE) -- ENTREPRISES MINIÈRES GLOBEX INC. (GMX – Bourse de Toronto, G1MN – Bourses de Francfort, Stuttgart, Berlin, Munich, Tradegate, Lang &...
Basilea-Logo.jpg
Basilea announces approval of antifungal Cresemba® (isavuconazole) for invasive aspergillosis in China
January 13, 2022 01:15 ET | Basilea Pharmaceutica AG
Chinese National Medical Products Administration (NMPA) granted Drug Approval License to Basilea’s license partner Pfizer Second approved indication after invasive mucormycosis in December 2021 ...
Basilea-Logo.jpg
Basilea gibt Marktzulassung des Antimykotikums Cresemba® (Isavuconazol) für invasive Aspergillose in China bekannt
January 13, 2022 01:15 ET | Basilea Pharmaceutica AG
Zulassung durch Chinesische National Medical Products Administration (NMPA) für Basileas Lizenzpartner Pfizer Zweite zugelassene Indikation nach invasiver Mukormykose im Dezember 2021 Basel, 13....
globex logo.jpg
Drill Results by Starr Peak Mining Ltd.
January 11, 2022 13:39 ET | Globex Mining Enterprises Inc.
ROUYN-NORANDA, Québec, Jan. 11, 2022 (GLOBE NEWSWIRE) -- GLOBEX MINING ENTERPRISES INC. (GMX – Toronto Stock Exchange, G1MN – Frankfurt, Stuttgart, Berlin, Munich, Tradegate, Lang &...
Christina Lake Cannabis Corp. Provides Operational Update and Announces Fourth Consecutive Quarter of Sales Growth, Ending Fiscal 2021
January 11, 2022 07:00 ET | Christina Lake Cannabis Corp.
VANCOUVER, British Columbia, Jan. 11, 2022 (GLOBE NEWSWIRE) -- Christina Lake Cannabis Corp. (the “Company” or “CLC” or “Christina Lake Cannabis”) (CSE: CLC) (OTCQB: CLCFF) (FRANKFURT: CLB) released...
Basilea-Logo.jpg
Basilea announces completion of patient enrolment in phase 3 ERADICATE study investigating ceftobiprole in bloodstream infections
January 11, 2022 01:15 ET | Basilea Pharmaceutica AG
Basel, January 11, 2022 Basilea Pharmaceutica Ltd. (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with infectious diseases and cancer, announced...
Basilea-Logo.jpg
Basilea gibt Abschluss der Patientenrekrutierung für Phase-3-Studie ERADICATE mit Ceftobiprol bei Blutbahninfektionen bekannt
January 11, 2022 01:15 ET | Basilea Pharmaceutica AG
Basel, 11. Januar 2022 Basilea Pharmaceutica AG (SIX: BSLN), ein biopharmazeutisches Unternehmen mit bereits vermarkteten Produkten und dem Ziel, Patienten zu helfen, die an Infektionen oder Krebs...
Basilea-Logo.jpg
Basilea exceeds 2021 financial guidance on preliminary revenue and year-end cash-position
January 10, 2022 01:15 ET | Basilea Pharmaceutica AG
Total revenue of CHF 148 million exceeding 2021 financial guidance, driven by 65% increase in non-deferred revenue contributions from Cresemba and ZevteraCHF 150 million year-end cash and financial...